Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 7,151–7,175 of 7,816 matching trials · page 287 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Alpha-synuclein in Cerebrospinal Fluid to Differentiate Alzheimer's Disease From Lewy Body Disease. NCT01876459 MRI; lumbar puncture; neuropsychological tests Runs in: France · 1 site |
NA other |
UNKNOWN | 265 | University Hospital, Strasbourg, France OTHER |
2013-06-18 |
|
Biomarker Study to Diagnose Alzheimer's Disease NCT01874418 Biomarker Runs in: South Korea · 1 site |
NA other |
UNKNOWN | 90 | Seoul National University Hospital OTHER |
2013-06-11 |
|
A Study to Evaluate the Use of Memantine In Combination With Anti-HIV Drugs to Treat AIDS Dementia Complex (ADC) NCT00000867 Memantine Runs in: United States · 19 sites |
PHASE2 symptomatic-cholinergic |
COMPLETED | 120 | National Institute of Allergy and Infectious Diseases (NIAID) NIH |
2013-06-10 |
|
Functional Magnetic Resonance Imaging Study of Jaw-tapping Movement on Memory Function NCT01873664 Jaw-tapping Runs in: South Korea · 1 site |
NA other |
UNKNOWN | 30 | Kyunghee University Medical Center OTHER |
2013-06-10 |
|
Deep Brain Stimulation (DBS) of the Nucleus Basalis Meynert (NBM) to Treat Cognitive Deficits in Light to Moderate Alzheimer's Disease NCT01094145 Deep brain stimulation Runs in: Germany · 1 site |
NA other |
COMPLETED | 6 | University of Cologne OTHER |
2013-06-07 |
|
Amyloid Accumulation After Mild Traumatic Brain Injury NCT01871610 [18F]AV-45 PET amyloid binding imaging |
PHASE2 other |
UNKNOWN | 40 | Chang Gung Memorial Hospital OTHER |
2013-06-07 |
|
Efficacy and Safety of Cilostazol in Patients of Vascular Cognitive Impairment-no Dementia (VCIND) NCT01872858 Aspirin; Cilostazol Runs in: China · 1 site |
NA other |
UNKNOWN | 200 | Huashan Hospital OTHER |
2013-06-07 |
|
NMDA-enhancing Agent for Treatment of Mild Cognitive Impairment and Mild Alzheimer's Disease NCT01600469 DAOI-B; Placebo Runs in: Taiwan · 1 site |
PHASE2 symptomatic-cholinergic |
COMPLETED | 86 | Chang Gung Memorial Hospital OTHER |
2013-06-04 |
|
Mirtazapine for Sleep Disorders in Alzheimer's Disease NCT01867775 Mirtazapine Runs in: Brazil · 1 site |
PHASE3 other |
UNKNOWN | 30 | Brasilia University Hospital OTHER |
2013-06-04 |
|
Geriatric Psychiatry and Pharmacovigilance NCT01858857 Runs in: Germany · 5 sites |
NA other |
UNKNOWN | 4,000 | Hannover Medical School OTHER |
2013-05-29 |
|
Study of the Effects of Cerefolin NAC on Inflammation Blood Markers in Older Individuals With Memory Complaints NCT00597376 Cerefolin NAC (a medical food); Cerefolin NAC placebo Runs in: United States · 1 site |
NA other |
COMPLETED | 104 | Rush University Medical Center OTHER |
2013-05-23 |
|
A Randomized, Double-blind, Placebo-controlled, Sequential Ascending, Single-dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2212 in Healthy Subjects NCT01221259 E2212; placebo Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 60 | Eisai Inc. INDUSTRY |
2013-05-22 |
|
An Study to Determine the Bioavailability of E2609 Tablets Compared to Capsules and the Effect of Food on Absorption NCT01716897 E2609 Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 18 | Eisai Inc. INDUSTRY |
2013-05-22 |
|
The Effect of a Pre- and Postoperative Orthogeriatric Service NCT01009268 Orthogeriatric intervention Runs in: Norway · 1 site |
NA other |
COMPLETED | 332 | Ullevaal University Hospital OTHER |
2013-05-16 |
|
Improving Well-being and Health for People With Dementia NCT01855152 Optimised WHELD intervention; Treatment as usual Runs in: United Kingdom · 1 site |
NA other |
UNKNOWN | 1,000 | professor Clive Ballard OTHER |
2013-05-16 |
|
Computer-Based Training for Mild Alzheimer's Disease NCT00319891 Computer-based Cognitive Training Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 6 | Posit Science Corporation INDUSTRY |
2013-05-15 |
|
Breaking the Cycle IV: Military PTSD (MPTSD) Treatment Study NCT01228539 TARGET (Trauma Affect Regulation); Prolonged Exposure Runs in: United States · 1 site |
NA other |
COMPLETED | 31 | UConn Health OTHER |
2013-05-13 |
|
The Efficacy, Tolerability and Safety of Donepezil (Aricept) in Parkinson's Disease Patients With Dementia NCT00165815 ARICEPT Runs in: Germany; Ireland · 4 sites |
PHASE3 symptomatic-cholinergic |
COMPLETED | — | Eisai Limited INDUSTRY |
2013-05-10 |
|
NAC-003 P.L.U.S. Program (Progress Through Learning Understanding & Support) NCT01370954 CerefolinNAC® Runs in: United States · 1 site |
NA other |
COMPLETED | 204 | Pamlab, Inc. INDUSTRY |
2013-05-09 |
|
Antipsychotic Discontinuation in Alzheimer's Disease NCT00417482 risperidone Runs in: United States · 7 sites |
PHASE4 other |
COMPLETED | 180 | New York State Psychiatric Institute OTHER |
2013-04-24 |
|
Pilot Study of Minocycline in Huntington's Disease NCT00277355 minocycline; Matching placebo Runs in: Canada; United States · 12 sites |
PHASE2|PHASE3 anti-inflammatory |
COMPLETED | 114 | Merit Cudkowicz NETWORK |
2013-04-19 |
|
Identifying Potential Effects of Liraglutide on Degenerative Changes NCT01469351 Liraglutide; non-active study drug Runs in: Denmark · 1 site |
NA GLP-1 |
COMPLETED | 34 | University of Aarhus OTHER |
2013-04-19 |
|
A Survey Study of the Treatment and Outcome Management in Patients Diagnosed With Alzheimer's Disease NCT00291421 |
NA other |
COMPLETED | 2,360 | Janssen Pharmaceutica N.V., Belgium INDUSTRY |
2013-04-16 |
|
Functional Brain Imaging of Medication Treatment Response in Mild Alzheimer's Disease Patients NCT00369603 Razadyne ER; Aricept Runs in: United States · 1 site |
PHASE4 other |
TERMINATED | 4 | Duke University OTHER |
2013-04-11 |
|
Pregnenolone Sulfate an Early Marker of the Memory Loss in Alzheimer's Disease NCT00912886 Runs in: France · 6 sites |
NA other |
COMPLETED | 90 | Assistance Publique - Hôpitaux de Paris OTHER |
2013-04-11 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial